Edwards Lifesciences Other liabilities remained flat by 0.0% to $6.10M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Significant fluctuations may signal changes in operational accruals or shifts in the valuation of non-core financial obligations.
This category encompasses miscellaneous obligations that do not fit into primary liability classifications like deposits...
Most financial institutions maintain a similar 'other' category, though the composition varies significantly by business model.
other_other_liabilities_fair_value_disclosure| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $6.10M | $6.10M |
| QoQ Change | — | +0.0% |